ATRC AtriCure Inc

0.00 (0.0%)
Pre Market
Last Updated: 06:18:21
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 0
Bid Price 44.21
Ask Price 70.07
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
AtriCure Inc ATRC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 43.91 06:18:21
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 32.51 - 59.61
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 43.91 USD

AtriCure Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.08B 47.35M - 330.38M -46.47M -0.98 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

AtriCure News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No ATRC Message Board. Create One! See More Posts on ATRC Message Board See More Message Board Posts

Historical ATRC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week41.7144.2340.4742.50349,6632.205.27%
1 Month45.5346.222840.4743.26317,581-1.62-3.56%
3 Months48.5559.6140.4749.23328,833-4.64-9.56%
6 Months40.9459.6139.02547.69298,0512.977.25%
1 Year39.0059.6132.5144.38307,3884.9112.59%
3 Years40.5489.1832.5154.51304,0933.378.31%
5 Years36.4989.1822.5746.94299,5907.4220.33%

AtriCure Description

AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.